Status:
COMPLETED
The Canada Lymph Node Score: A Feasibility Randomized Controlled Trial
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Collaborating Sponsors:
McMaster University
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For patients diagnosed with early stage Non-Small Cell Lung Cancer (NSCLC) on preoperative computerized tomography (CT) and positron emission tomography (PET) scans, surgical resection is usually the ...
Eligibility Criteria
Inclusion
- Referred to have EBUS for staging of confirmed or suspected NSCLC
- Completed both a CT and PET scans
- cN0-cN1 disease indicated on CT and PET scans
Exclusion
- Patients with cN0 disease, peripheral tumours and tumours \< 2 cm in diameter (they do not require staging)
- Evidence of cN2 disease or higher on CT and PET scan
Key Trial Info
Start Date :
May 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 8 2020
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03859349
Start Date
May 6 2019
End Date
June 8 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6